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Purpose: The goal of an all-autogenous policy for infrainguinal rterial bypass requires that 
many bypasses be performed with alternative autogenous veins (AAV) because an adequate 
length of ipsilateral or contralateral greater saphenous vein (GSV) is not available. The 
durability and efficacy of infrainguinal vein bypasses constructed ofvenous conduits other 
than a single segment of greater saphenous vein (SSGSV) is, however, questioned. 
Methods: AAV and GSV bypasses were reviewed from 1980 through 1994. Patients who 
required bypass to the popliteal or a tibial artery were compared for vascular surgical 
history and vascular disease risk factors and life-table survival. AAV and SSGSV 
procedures were compared for indications for surgery, morbidity and mortality rates, limb 
salvage rates in patients who underwent surgery for limb-salvage indications, ubsequent 
need for revision, and life-table-assisted primary patency. 
Results: Nine htmdred nineteen autogenous vein bypasses were performed to the popliteal 
or a tibial artery- 187 (20%) with AAVs, including whole or partial arm vein conduits in 
144 grafts (77%). One hundred fourteen AAVs (61%) required vein splicing. The 
mortality rate was 2% for SSGSV bypasses and 1% for AAV bypasses. The morbidity rate 
was higher for GSV sttrgery as a result of increased wound complications (11% vs 5%; 
p -- 0.02). Sixty-seven percent of patients with AAV bypass extremities had undergone 
previous ipsilateral arterial surgery, compared with 20% of patient with SSGSV bypasses 
(p = 0.0005). AAV bypasses were more likely to be to a tibial artery (71% vs 45%; 
p < 0.0001). Twelve percent of SSGSV and 15% of AAV popliteal bypasses required 
revision (p = NS). The 5-year assisted primary patencies were 82%, 77%, and 63%, with 
limb salvage rates of 91%, 86%, and 74% for ipsilateral SSGSV, contralateral SSGSV, and 
AAV femoropopliteal bypasses, respectively. Twelve percent of SSGSV and 30% of AAV 
tibial bypasses required revision (p = 0.0001). The 5-year assisted primary patencies were 
74%, 82%, and 72%, with limb salvage rates of 84%, 92%, and 78% for ipsilateral SSGSV, 
contralateral SSGSV, and AAV femorotibial bypasses, respectively. 
Conclusion: AAV bypasses can provide overall results comparable with SSGSV bypasses. 
(J VASC SURG 1996;23:272-80.) 
A normal ipsilateral greater saphenous vein 
(GSV) is the preferred conduit for infrainguinal 
lower-extremity arterial revascularization.1 Un- 
fortunately, many patients who require lower- 
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extremity revascularization do not have an ade- 
quate length of usable ipsilateral GSV. In the 
absence of usable ipsilateral GSV, conduit options 
for infrainguinal bypass include prosthetic grafts and 
alternate sources of autogenous vein. Our strong 
institutional preference is to use autogenous vein 
for infralnguinal bypass whenever possible. Re- 
sults of the use of alternate sources of autog- 
enous vein for lower-extremity revascularizafion to 
the popliteal and tibial arteries in comparison 
with those obtained with single segments of re- 
verse greater saphenous vein (SSGSV) (both ipsi- 
lateral and contralateral) form the basis for this 
report. 
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PATIENTS AND METHODS 
Operative technique and follow-up. The tech- 
nique for lower-extremity autogenous reverse vein 
arterial bypass has been described previously) Prin- 
cipal points include the use of multiple operating 
teams to simultaneously harvest and prepare the vein 
and expose proximal and distal anastomotic sites; 
distal graft origins; liberal use of venectomy and 
venovenostomies to achieve high-quality conduits; 
reversal of the conduit; and, for the most part, 
anatomic tunneling. Preferred secondary conduits in 
the absence of adequate ipsilateral GSV are contralat- 
eral GSV, followed by arm vein. With multiple 
operating teams, this strategy of vein harvesting 
permits imultaneous vein harvesting and exposure of 
anastomotic sites. Potential venous conduits were not 
used if they were obviously sclerotic, did not distend 
well at the time of vein preparation, orwere less than 
approximately 3 mm in diameter after distension. In 
recent years increasing emphasis has been placed on 
the use of preoperative nous mapping with duplex 
ultrasound to assess before surgery the best alterna- 
tive vein source. 
Bypasses were routinely assessed uring surgery 
with continuous-wave Doppler scans and, in a 
minority of cases, with electromagnetic flow mea- 
surements. Completion angiography was infre- 
quently used ( < 10% of patients) and was restricted 
to procedures in which the continuous-wave Doppler 
examination or flow measurements suggested a
technical problem. 
Patients were seen for follow-up every 3 months 
for i year and every 6 months thereafter. In the early 
portion of the series, graft patency was assessed by 
physical examination and by determination f ankle- 
brachial Doppler blood pressure ratios. Since 1985, 
graft patency and function have also been assessed by 
duplex scanning. From 1985 to about 1990 angiog- 
raphy and possible graft revision were prompted 
primarily by the finding of a midgraft peak systolic 
velocity of < 45 cm/sec. From 1990 to the present 
grafts were examined intheir entirety with color-flow 
duplex scanning, and revision was considered if the 
midgraft peak systolic velocity was < 45 cm/sec or if 
a stenosis with a velocity > 200 cm/sec was identified. 
Before graft revision all patients underwent angiog- 
raphy. Significant graft lesions were treated by 
reoperation. 3 
Patients and procedures. The computerized 
vascular surgical database at the Oregon Health 
Sciences University was reviewed for the period 1980 
through 1994. All patients who underwent autog- 
enous vein bypass to the popliteal or a tibial artery 
proximal to the ankle for lower-extremity schemia 
were identified. Procedures were excluded if they 
consisted solely of endarterectomy or if they involved 
prosthetic grafts, revision of a previously placed but 
still patent autogenous vein graft, or bypass to an 
inframalleolar tery. 
Patients were analyzed for risk factors for athero- 
sclerosis, previous vascular surgery, availability of 
ipsilateral GSV for the bypass, previous ipsilateral 
lower-extremity arterial bypass, and survival (with 
life-table analysis). 
For purposes of this report, an alternative autog- 
enous vein (AAV) bypass is defined as any autog- 
enous procedure that uses a venous conduit other 
than SSGSV. Four types of procedures were 
considered: (1) bypass to the popliteal artery with an 
SSGSV (ipsilateral or contralateral), (2) bypass to the 
popliteal artery with AAV, (3) bypass to a tibial 
artery with an SSGSV, and (4) bypass to a tibial 
artery with AAV. Each procedure was reviewed for 
associated complications (myocardial infarction, 
stroke, pneumonia, respiratory failure that required 
intubation, hemorrhage, and wound infection) and 
mortality rate, as well as its indication, source of 
autogenous conduit, and, when applicable, the num- 
ber of venovenostomies required to achieve an 
autogenous conduit of adequate quality and sufficient 
length. In addition, the need for repeat surgery to 
maintain graft patency, life-table-assisted primary 
patencies, and limb salvage rates in patients who 
underwent surgery for limb-salvage indications were 
calculated for each group. 4
Statistical analysis. Data were collected and 
stored in a file-management database (DataEase, 
Trumbull, Conn.). Descriptive results are expressed 
as mean _+ SEM. Statistical comparisons between 
categoric parameters were performed with X 2 analy- 
sis. Life-table analysis was used to estimate graft 
patency by the Peto life-table method, and compari- 
sons between life-table patency rates were made with 
the Mantel-Cox log rank test of significance. 5 Life- 
table survival, limb salvage rates, and patency results 
were reported when SEM < 10%, and statistics were 
considered significant ifp < 0.05. 
RESULTS 
Patients. From 1980 to 1994, 1046 lower- 
extremity bypass (LEB) surgeries for chronic lower- 
extremity ischemia were performed in 760 patients. 
Of these procedures, 919 were autogenous vein 
bypasses to the popliteal or a tibial artery. Table I 
details the demographics and vascular risk factors in 
these patients. Patients whose limbs required AAV 
JOURNAL OF VASCULAR SURGERY 
274 Gentile et al. February 1996 
Table I. Patient demographics and vascular isk factors 
Characteristic G S V bypasses Alternative vein bypasses p ~ 
Men : women 56% neb :44% women 57% men :43% women NS 
Average age 65 years 69 years NS 
Smoking history 76% 68% 0.04 
Heart disease 60% 73% 0.003 
Hypertension 66% 70% NS 
Diabetes 47% 43% NS 
Renal failure 15% 9% NS 
Previous ipsilateral bypass 20% 67% < 0.0005 
GSV, Greater saphenous vein. 
LEB were similar in most respects to patients 
undergoing LEB with SSGSV; however, those that 
required AAV were more likely to have had a 
previous ipsilateral arterial procedure (67%) than 
those in whom SSGSV was used as the bypass 
conduit (20%) (p < 0.0005). The proportion of 
bypasses to a tibia] artery also was higher in patients 
who required AAV (71%) than in those who 
required SSGSV (45%) operations (p < 0.0005); 
however, the indication for surgery was similar in 
patients who underwent AAV LEB (82% for limb 
salvage) and in those who underwent SSGSV LEB 
(76% for limb salvage) (p = NS). Five-year life-table 
survival rates of patients who underwent bypass to 
the popliteal artery with ipsilateral SSGSV, contralat- 
era] SSGSV, and AAV were 52%, 57%, and 70%, 
respectively (p = NS for patients who underwent 
SSGSV poplitea] bypasses compared with patients 
who underwent AAV popliteal bypasses) (Table II). 
Five-year life-table survival rates of patients who 
underwent bypass to a tibia] artery with ipsilateral 
SSGSV, contralateral SSGSV, and AAV were 47%, 
49%, and 56%, respectively (p = NS comparing all 
patients with SSGSV tibial bypasses to patients with 
AAV tibia] bypasses) (Table II). 
Distribution of  procedures. In 38% of all LEB 
(394 of 1046), the ipsilatera] extremity did not have 
an adequate GSV. In 42 the GSV had been used for 
previous coronary artery bypass surgery. In the 
remaining cases, the vein had been harvested for 
previous leg bypass surgery; had been removed for 
venous insufficiency; or was too small, sclerotic, or 
varicose to be used for bypass. Seventy-four bypasses 
(7%) were performed with prosthetic grafts in 
patients without an identifiable usable autogenous 
vein. These cases are not considered further. Six 
hundred thirty-nine of the operations (61%) were 
performed with ipsilateral SSGSV and 93 (9%) with 
contralateral SSGSV to the popliteal or a tibial artery. 
One hundred eighty-seven autogenous proce- 
dures (20%) were performed to the popliteal or a 
tibial artery with an AAV conduit: an arm vein, a 
lesser saphenous vein, a superficial femoral vein, or 
multiple joined vein segments. Of  the AAV bypasses, 
97 were arm veins only (whole length or composite), 
11 were lesser saphenous veins, 5 were superficial 
femoral veins, 27 were composite GSVs; and 47 were 
composite veins from different anatomic sites, pri- 
marily arm vein and GSV or arm vein and lesser 
saphenous vein. The arm vein conduit was used 
wholly or in part in 144 of 187 (77%) AAV LEBs. 
Splicing of multiple vein segments was required 
in 114 AAV bypasses (61%). In spliced grafts, 1 
venovenostomy was required in 87 grafts (76%), 2 
venovenostomies in 23 grafts (19%), 3 in 3 grafts, 
and 4 in 1 AAV LEB. Overall, 406 SSGSV bypasses 
(contralateral plus ipsilatera]) were to the popliteal 
artery, 326 were to a tibial artery (contralateral p us 
ipsilateral GSV), 54 were AAV bypasses to the 
popliteal artery, and 133 were AAV bypasses to a 
tibia] artery. 
Mortality and complication rates. Two patients 
(1.1%) died within 30 days ofAAV LEB. Fourteen 
patients (2%) died within 30 days of revasculariza- 
tion with SSGSV (p = NS). The complication rate 
was 12% in the AAV procedures and 19% in the 
SSGSV procedures (p = 0.03). The incidence of 
perioperative wound complications was higher in the 
SSGSV (11%) than in the AAV (5%) procedures 
(p = 0.02). No long-term complications occurred 
with arm vein harvest sites. One patient in whom the 
superficial femoral vein was used as the bypass 
conduit had significant chronic leg edema after 
surgery. 
No limb loss was attributed to the use of 
contra]atera] GSV. Seven donor extremities (7.5%) 
from which contralateral GSVs were removed ulti- 
mately required a bypass in that leg as well. In two of 
the seven, the indication for revascularization was 
failure of the GSV harvest site to heal. Thus in only 
2% of patients in whom the contralatera] GSV was 
used as the bypass conduit did use of the contralateral 
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Table II. Life-table patient survival rates 
Interval Cumulative 
(too) At  risk Dead Withdrawn survival SEM 
Ipsilateral GSV ~mo- 0 323 3 6 0.991 0.00 
ropopfi~albyp~s 6 314 21 35 0.921 0.01 
12 258 14 29 0.869 0.01 
24 215 11 36 0.820 0.02 
36 168 18 20 0.727 0.02 
48 130 17 27 0.621 0.03 
60 86 13 19 0.515 0.03 
Contralateral GSV ~mo- 0 35 0 1 1.000 0.00 
ropopfite~ bypass 6 34 0 7 1.000 0.00 
12 27 2 0 0.926 0.04 
24 25 1 4 0.886 0.05 
36 20 0 5 0.886 0.06 
48 15 1 3 0.820 0.08 
60 11 3 2 0.574 0.11 
Alterna~ vein ~mo- 0 51 0 2 1.000 0.00 
ropophtealbypass 6 49 3 7 0.934 0.03 
12 39 2 0 0.886 0.04 
24 37 0 4 0.886 0.04 
36 33 0 5 0.886 0.05 
48 28 4 5 0.747 0.07 
60 19 1 8 0.697 0.08 
Ipsila~ral GSV tibial 0 244 5 8 0.979 0.00 
byp~s 6 231 24 31 0.870 0.02 
12 176 15 24 0.791 0.02 
24 137 12 23 0.715 0.03 
36 102 10 25 0.635 0.03 
48 67 10 17 0.526 0.04 
60 40 4 9 0.467 0.05 
Contrala~ral GSV tibial 0 58 2 2 0.965 0.02 
bypass 6 54 3 12 0.905 0.03 
12 39 2 3 0.857 0.05 
24 34 2 5 0.803 0.06 
36 27 2 7 0.735 0.07 
48 18 2 2 0.648 0.09 
60 14 3 4 0.486 0.09 
Alterna~ vein tibialbypass 0 111 1 1 0.991 0.00 
6 109 6 14 0.933 0.02 
12 89 6 13 0.865 0.03 
24 70 6 15 0.782 0.04 
36 49 6 10 0.676 0.05 
48 33 2 8 0.629 0.06 
60 23 2 9 0.561 0.07 
GSV, Greater saphenous vein. 
GSV result in the need for revascularization f that 
extremity. 
Patency and limb salvage. Mean follow-up after 
bypass to the popliteal or a tibia] artery with AAV was 
36 months and 25 months, respectively (range, 1 to 
144 months and 1 to 120 months). The mean 
follow-up after SSGSV bypass to the poplitcal or a 
tibial artery was 34 months and 25 months, respec- 
tively (range, I to 179 months and 1 to 146 months). 
No difference was found in the need for late 
revision or patency of bypasses composed of ipsilat- 
eral versus contralateral SSGSV (Table III). Twelve 
percent of SSGSV popfiteal bypasses and 15% of 
AAV popliteal bypasses required late revision to 
maintain graft patency (p = NS). The 5-year assisted 
primary patency rates for bypass to the popliteal 
artery with ipsilateral SSGSV, contralateral SSGSV, 
and AAV were 82%, 77%, and 63%, respectively 
(p = NS comparing all SSGSV popliteal bypasses to 
AAV popliteal bypasses) (Table III). Twelve percent 
of GSV tibial bypasses and 30% of AAV tibial 
bypasses required late revision to maintain graft 
patency (p = 0.0001). Five-year assisted primary 
patency rates for bypass to a tibial artery with 
ipsilateral SSGSV, contralateral SSGSV, and AAV 
was 74%, 82%, and 72%, respectively (p = NS 
comparing all SSGSV tibial bypasses to AAV tibial 
bypasses) (Table III). 
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Table III. Assisted primary patency rates 
Interval Cumulative 
(mo) At  risk Occluded Withdrawn patency SEM 
Ipsilateral GSV femo- 0 371 6 9 0.984 0.00 
ropopliteal bypass 6 356 16 60 0.936 0.01 
12 280 5 41 0.918 0.01 
24 234 6 51 0.891 0.01 
36 177 4 42 0.868 0.02 
48 131 2 43 0.852 0.02 
60 86 3 29 0.816 0.03 
Contralateral GSV femoro- 0 35 1 1 0.971 0.02 
popliteal bypass 6 33 2 6 0.906 0.04 
12 25 1 2 0.868 0.06 
24 22 1 3 0.825 0.07 
36 18 1 4 0.774 0.08 
48 13 0 3 0.774 0.10 
60 10 0 5 0.774 0.11 
Alternate vein femo- 0 54 1 2 0.981 0.01 
ropopliteal bypass 6 51 3 11 0.916 0.03 
12 37 0 2 0.916 0.04 
24 35 1 6 0.888 0.05 
36 28 3 3 0.788 0.06 
48 22 2 7 0.703 0.08 
60 13 1 6 0.633 0.10 
Ipsilateral GSV tibial 0 268 6 16 0.977 0.00 
bypass 6 246 7 58 0.946 0.01 
12 181 9 32 0.894 0.02 
24 140 4 38 0.864 0.02 
36 98 3 31 0.833 0.03 
48 64 2 29 0.800 0.04 
60 33 2 9 0.744 0.06 
Contralateral GSV tibial 0 58 2 4 0.964 0.02 
bypass 6 52 4 14 0.878 0.04 
12 34 1 5 0.850 0.05 
24 28 1 5 0.817 0.06 
36 22 0 8 0.817 0.07 
48 14 0 5 0.817 0.09 
60 9 0 5 0.817 0.11 
Alternate vein tibial 0 133 4 2 0.970 0.01 
bypass 6 127 1 18 0.863 0.02 
12 96 3 21 0.833 0.03 
24 72 2 22 0.806 0.04 
36 48 3 14 0.747 0.05 
48 31 1 9 0.719 0.06 
60 21 0 9 0.719 0.08 
GSV, Greater saphenous vein.- 
Five-year limb salvage rates for extremities that 
underwent bypass for limb salvage indications to the 
popliteal artery with ipsilateral SSGSV, contralateral 
SSGSV, and AAV were 91%, 86%, and 74%, 
respectively (p = NS comparing all SSGSV popliteal 
bypasses to AAV popliteal bypasses) (Table IV). 
Five-year limb salvage rates for extremities that 
underwent bypass to a tibial artery for limb salvage 
indications with ipsilateral SSGSV, contralateral 
SSGSV, and AAV were 84%, 92%, and 78%, 
respectively (p = NS comparing all SSGSV bypasses 
to AAV bypasses) (Table IV). 
DISCUSSION 
Technical difficulty, perceived morbidity, and 
questionable durability have all combined to limit 
enthusiasm for AAV lower-extremity b pass proce- 
dures. Some early reports of alternative veins used as 
bypass conduits were disappointing in that they 
demonstrated a high early occlusion rate in bypasses 
constructed with cephalic and basilic vein. 6,7 In recent 
years, however, the consensus has grown that AAVs, 
although they remain a second choice to good- 
quality saphenous veins, are a valuable adjunct for 
infrainguinal bypass. Table V shows that AAVs can 
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Table IV. Limb salvage rates in patients who underwent bypass to the popliteal or a tibial artery 
for limb-saivage indications 
Interval Cumulative limb 
(mo) At  r i sk  Amputated Withdrawn salvage SEM 
Ipsilateral GSV femo- 0 247 4 6 0.984 0.00 
ropopliteal bypass 6 237 7 45 0.952 0.01 
12 185 1 27 0.946 0.01 
24 157 1 38 0.939 0.01 
36 118 3 29 0.912 0.02 
48 86 0 33 0.912 0.02 
60 53 0 17 0.912 0.03 
Contralateral GSV femoro- 0 27 1 0 0.963 0.03 
popfiteal bypass 6 26 0 6 0.963 0.03 
12 20 1 1 0.914 0.05 
24 18 1 4 0.857 0.07 
36 13 0 3 0.857 0.08 
48 10 0 3 0.857 0,10 
60 7 0 2 0.857 0,12 
Alternate vein femo- 0 40 0 2 1.000 0.00 
ropopliteal bypass 6 38 1 9 0.970 0.02 
12 28 0 1 0.970 0,03 
24 27 1 3 0.932 0,04 
36 23 0 1 0.932 0.05 
48 22 1 6 0.883 0.06 
60 15 2 5 0.742 0.09 
Ipsilateral GSV tibial 0 233 5 14 0.978 0.00 
bypass 6 214 8 49 0.937 0.01 
12 157 3 30 0.917 0.02 
24 124 0 33 0.917 0.02 
36 91 1 30 0.905 0.02 
48 60 0 27 0.905 0.03 
60 33 2 8 0.843 0.05 
Contralateral GSV tibial 0 51 0 4 1.000 0.00 
bypass 6 47 2 13 0.951 0.03 
12 32 1 4 0.920 0.04 
24 27 0 6 0.920 0.05 
36 21 0 7 0.920 0.05 
48 14 0 5 0.920 0.06 
60 9 0 5 0.920 0.08 
Alternate vein tibial 0 113 1 2 0.991 0.00 
bypass 6 110 9 16 0.904 0.02 
12 85 3 20 0.868 0.03 
24 62 3 19 0.819 0.04 
36 40 0 16 0.819 0.05 
48 24 1 8 0.778 0.07 
60 15 0 6 0.778 0.09 
GSV, Greater saphenous vein. 
serve as acceptable arterial substitutes for lower- 
extremity bypass, although primary patencies have 
not been generally equivalent to GSV bypass. 8-15 
AAV bypass is without question more technically 
difficult han procedures that use SSGSV. Arm veins 
are thin and easily damaged uring harvesting. 
Venovenostomies are often required for AAV by- 
passes, whereas dissections of arterial anastomotic 
sites are frequently in areas with extensive scarring 
from previous surgeries. In our experience, these 
difficulties are addressed by the use of multiple 
operating teams. This approach allows each portion 
of the surgery to be completed in a deliberate and 
meticulous fashion but still allows the entire proce- 
dure to be completed promptly. 
This report shows that assisted primary patency 
and limb salvage rates in patients who underwent 
AAV bypasses are essentially equal to that of those 
undergoing GSV bypasses, although this equality is 
achieved at the cost of an increased number of 
revisions for bypasses to tibial arteries. We conclude 
that the results of AAV bypass, despite the increased 
technical difficulties of the surgery and increased 
requirement for graft maintenance, are good enough 
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Table V. Results of lower-extremity revascularization with alternative vein bypass conduits 
Number of patients 1-year primary 5-year primary 
Authors Year (grafts) patency rate patency rate Reference no. 
Graham/Lusby 1982 37 71 49 8 
Schulman/Badhey 1982 41 62 31 9 
Andros/Harris 1986 88 74 51 10 
Schuhnan/Yatco 1987 41 64 57 11 
Balashi/Cantelmo 1989 36 73 ~ 12 
Sesto/Sullivan 1992 35 49 ~ 13 
Harward/Coe 1992 43 67 ~ 14 
Chang/Leather 1995 184 72 45 ]- 15 
~Results not given. 
t4-year patency rate. 
to justify use of these conduits in preference to 
prosthetics. This favorable conclusion can be made 
despite the fact that alternative vein conduits, at least 
in this series, were placed in what may be a less 
optimal patient population in which the patients 
required more infrapopliteal bypasses and had a high 
rate of previous failed bypasses. 
Many reasons can be given to explain why AAV 
bypasses require more late revisions to maintain 
patency. The most obvious are the frequency with 
which arm veins have had previous venipunctures, 
acceptance in some cases of smaller diameters of some 
alternative conduits, and the need for one or more 
venovenostomies to achieve a conduit of adequate 
length. Stonebridge t al.16 noted that 20 of 27 
infrainguinal rm vein bypass conduits (74%) have 
intraluminal bnormalities detected by routine use of 
vein graft angioscopy. Regardless of the cause of the 
need for alternative vein conduit revisions, vascular 
laboratory surveillance of alternative vein conduits is 
clearly important in achieving optimal results. M- 
though it is possible that we may have been able to 
achieve a decreased need for late revision by using 
completion angiography in all of our procedures, the 
results achieved in this series and the need for late 
revision are compatible with other modern reports in 
which completion arteriography is apparently ob- 
tained routinely. ~6 
An interesting finding is that the alternative vein 
bypasses in this series were associated with a 10w 
complication rate. The mortality rate was no different 
from that of saphenous vein procedures. The mor- 
bidity rate was actually lower, which reflects the low 
number of wound complications a sociated with arm 
vein harvest sites in this predominately arm-vein 
series. 
No limb loss was attributable to preferential use 
of the contralateral GSV when the ipsilateral GSV 
was not available or was unusable. As might be 
expected, no difference was found in the patency of 
GSV conduits regardless of whether they came from 
the ipsilateral or contralateral lower extremity. Al- 
though concern may exist that the contrahteral 
saphenous vein should be spared for future contralat- 
eral leg bypass or coronary bypass, our data do not 
support this argument. Mthough it is true that 
approximately 10% to 20% of patients who require 
vascular surgery have already undergone coronary 
artery bypass grafting before having peripheral vas- 
cular symptoms, only 0.4% to 4.5% of patients 
require coronary artery bypass grafting after periph- 
eral bypass urgery. 17'18 It is our firm conviction that 
the optimal surgery should be performed in the 
current setting without regard to anticipated future 
conduit requirements. 
CONCLUSION 
The data presented here and elsewhere clearly 
justify the use of AAV and contralateral GSV for 
infrainguinal rterial bypass when the ipsilateral GSV 
is unavailable or unsuitable for use. Our preference is 
to first use the contralateral GSV and, if that is not 
available, to then use arm veins. The use of multiple 
operating teams makes these procedures reasonably 
efficient. Despite the need for increased graft revi- 
sions, overall continuous graft patency and limb 
salvage rates are statistically equal to those of GSV 
conduits and are clearly superior to prosthetic on- 
duits. 
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DISCUSSION 
Dr. Michael Belkin (Boston, Mass.). I would like to 
congratulate the vascular surgeons from Oregon on yet 
another excellent series of infrainguinal rterial reconstruc- 
tions. They have confirmed that successful bypass urgery 
and durable limb salvage can be achieved in the absence of 
the GSV. Nonetheless, these operations are tedious and 
labor-intensive, and demand a high level of dedication. As 
vascular surgeons continue to push the envelope further in 
limb-salvage surgery, it is increasingly clear that a major 
factor that influences the success of a salvage operation is 
how hard the surgeon is willing to work to obtain the best 
available conduit. Good-quality autogenous vein is the 
optimal conduit for infrainguinal reconstruction, and if it's 
harvested and prepared carefully, it makes little difference 
whether it comes from the arm, the lesser saphenous vein, 
or the GSV. I would like to ask the authors the following 
questions. 
When we use arm vein, we prefer to use the cephalic 
vein because of its favorable size and ease of harvest. 
Frequently, however, we must use the basilic vein. Because 
this vein is very large in caliber at its upper end, we find it 
preferable to lyse the valves and place this vein in a 
nonreversed configuration. Please comment on how you 
handle the technical disadvantages of the significant size 
mismatch when you anastomose the larger basilic vein to a 
small tibial artery. 
The authors' abstract focused on primary patency rates 
and demonstrated superior results for GSV over alternative 
vein. The manuscript, however, focused on assisted pri- 
mary patency rates where alternative vein grafts performed 
equally well. This difference points out the value of graft 
surveillance and emphasizes how the patency of alternative 
vein grafts can be effectively maintained through recogni- 
tion and repair of graft defects. Does your surveillance 
regimen for alternative vein grafts differ from other grafts? 
We prefer to place akernative vein grafts in subcutaneous 
tunnels where they are simple to both monitor and revise. 
Given these advantages, would you please comment on 
your preference for deep anatomic tunneling where moni- 
toring and revision are more difficult? 
Previous reports from your institution have docu- 
mented 5-year survival rates ranging from 12% to 30%. 
Five-year patency and limb salvage rates of 80% to 90% 
lose much of their gleam if few patients urvive to enjoy 
them. In today's report, however, you've noted 5-year 
patient survival rates ranging from 50% to 70%. These 
rates are more consistent with modern series from other 
institutions including our own. In light of the fact that the 
time frame for this series, 1980 to 1994, included periods 
that were examined in your previous tudies, how do you 
account for the significant improvement in survival rates? 
Assuming that none of your patients have returned from 
the dead to participate in this series, how has your 
long-term management and cardiac risk modification 
changed? 
Dr. Gregory Moneta. The first question was how do 
we address the problem of size discrepancy with a large 
basilic vein and the technical difficulties of anastomosing it 
to a tibial artery. We have the same approach to arm veins 
as do Dr. Belkin and the Brigham group in that, in general, 
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we will use a cephalic vein first when we use arm veins. 
The basilic vein, although it's a very usable vein and is 
almost always available, is not very long and under most 
circumstances will not reach to a tibial artery. When we 
use basilic veins in combination with other veins, we use 
them for the proximal portion of the composite graft, 
avoiding the problem of anastomosing it to a tibial artery. 
When a basllic vein does need to be anastomosed to a 
tibial artery, instead of just slitting the vein to make the 
hood of the vein graft we will obliquely excise a portion 
of the vein hood so that the vein graft is not bulbus at 
the site of anastomosis. 
Do we use different strategies of surveillance for 
alternative vein grafts? So far we have not. Our data 
indicate that possibly we should. The grafts that go to tibial 
arteries perhaps hould be looked at more intensely after 
surgery or perhaps evaluated more carefully in the operat- 
ing room to try and lower the high revision rate required 
for alternative vein bypasses to the tibial arteries. 
Are there any advantages to the anatomic position? 
There are no overwhelming advantages. We've used it 
because we have found it to be satisfactory; it allows the 
conduit o be marginally shorter and avoids potential graft 
exposure should a wound problem occur. Although graft 
revisions are marginally technically more difficult with an 
anatomically tunneled graft, we have not found them to be 
particularly onerous. 
How do we account for the improvement in the patient 
survival rate? I'm not sure I know. The patients that we are 
operating on now are certainly having more operations. 
They clearly have to survive to have more operations, o 
there may be some selection in that regard. We are using 
more warfarin than we have in the past, and although I'm 
not convinced warfarin prolongs graft patency, it may help 
survival rates in these patients. There have been no 
resurrections. 
Dr. O. Wil l iam Brown (Southfield, Mich.). Have you 
developed any criteria that allow you to determine when 
the portion of the saphenous vein below the knee may be 
safely harvested from the contralateral extremity? 
Dr. Moneta. If the patient has rest pain or an ischemic 
ulceration in the leg, we'll avoid the use of the contralateral 
saphenous vein. Otherwise we will take the vein even in 
patients with ankle brachial indices as low as 0,4. In such 
extreme cases, however, we generally will not harvest he 
vein to the ankle and will stop at midcalf. 
Dr. Dhiraj M. Shah (Albany, N.Y.). I congratulate he 
authors for bringing to our attention that alternative vein 
sources at least perform equally well as conventional 
sources. In your series, I see a paucity of the use of the lesser 
saphenous vein. Is that a natural aversion to that conduit or 
do you have bad experience with it? 
Also, did you analyze your data in terms of the number 
of pieces of vein that you have used, i.e., one, two, or three 
pieces? Do they perform differently? As our numbers are 
increasing for these alternative bypasses, we are seeing that 
more pieces of vein do not seem to perform as well as one 
or two pieces. The venovenostomy may be a problem. 
When you mention your assisted primary patency rate and 
number of revisions, where is the problem? Is it at the 
anastomosis, venovenostomy, or a bad piece of vein that 
you have to replace again? 
Dr. Moneta. Our tendency to not use lesser saphenous 
vein has a lot to do with our operative approach to these 
patients. We like to harvest he vein and expose proximal 
and distal anastomotic sites at the same time, and that is 
easier for us to do with arm veins than with lesser 
saphenous veins. This approach minimizes operative time 
and the time the vein is explanted. 
I don't know whether the number of pieces of vein has 
an influence on the overall need for revision. We don't have 
enough grafts with three or more pieces to make a definite 
statement. I  is my impression that the venovenostomy sites 
for us are not a particular problem. We do not usually 
perform patch angioplasties, however, to repair a stenotic 
vein graft. We prefer interposition grafts for these proce- 
dures and usually do not directly expose the site of stenosis. 
Because we don't expose the site of the stenosis, it may be 
that our impression that the venovenostomies are not a 
problem is incorrect. 
